Financial reports
10-K
2023 FY
Annual report
5 Mar 24
10-Q
2023 Q3
Quarterly report
31 Oct 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
20 Apr 23
10-K
2022 FY
Annual report
23 Feb 23
10-Q
2022 Q3
Quarterly report
20 Oct 22
10-Q
2022 Q2
Quarterly report
21 Jul 22
10-Q
2022 Q1
Quarterly report
21 Apr 22
10-K
2021 FY
Annual report
24 Feb 22
10-Q
2021 Q3
Quarterly report
21 Oct 21
Current reports
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
14 Mar 24
8-K
Regulation FD Disclosure
13 Mar 24
8-K
Plus Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
5 Mar 24
8-K
Regulation FD Disclosure
20 Nov 23
8-K
Other Events
31 Oct 23
8-K
Plus Therapeutics Reports Third Quarter 2023 Financial Results and Business Highlights
31 Oct 23
8-K
Plus Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights
14 Aug 23
8-K
Other Events
16 May 23
8-K
Plus Therapeutics Announces Reverse Stock Split
28 Apr 23
8-K
Submission of Matters to a Vote of Security Holders
21 Apr 23
Registration and prospectus
S-1/A
IPO registration (amended)
8 Mar 24
424B3
Prospectus supplement
22 Nov 23
S-1
IPO registration
22 Nov 23
S-1
IPO registration
13 Nov 23
424B3
Prospectus supplement
21 Aug 23
S-1
IPO registration
9 Aug 23
424B5
Prospectus supplement for primary offering
9 Sep 22
424B3
Prospectus supplement
17 Aug 22
S-1
IPO registration
8 Aug 22
424B5
Prospectus supplement for primary offering
14 Jan 22
Proxies
DEF 14A
Definitive proxy
7 Mar 23
PRE 14A
Preliminary proxy
24 Feb 23
DEFA14A
Additional proxy soliciting materials
7 Apr 22
DEF 14A
Definitive proxy
7 Apr 22
PRE 14A
Preliminary proxy
28 Mar 22
DEFA14A
Additional proxy soliciting materials
5 Apr 21
DEF 14A
Definitive proxy
5 Apr 21
DEF 14A
Definitive proxy
13 May 20
PRE 14A
Preliminary proxy
1 May 20
DEF 14A
Definitive proxy
18 Apr 19
Other
EFFECT
Notice of effectiveness
21 Nov 23
CORRESP
Correspondence with SEC
17 Nov 23
UPLOAD
Letter from SEC
17 Nov 23
EFFECT
Notice of effectiveness
21 Aug 23
CORRESP
Correspondence with SEC
16 Aug 23
UPLOAD
Letter from SEC
16 Aug 23
EFFECT
Notice of effectiveness
18 Aug 22
CORRESP
Correspondence with SEC
15 Aug 22
UPLOAD
Letter from SEC
15 Aug 22
EFFECT
Notice of effectiveness
13 Sep 21
Ownership